MacroGenics | MGNX - Current Liabilities


MacroGenics reported $44.47M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
AbbVie USD 39.39B 376M Sep/2025
Amgen USD 21.79B 1.32B Sep/2025
AstraZeneca USD 34.05B 518M Sep/2025
Biogen USD 3.29B 106.3M Sep/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Daiichi Sankyo JPY 778.55B 77.51B Dec/2025
Eli Lilly USD 40.14B 1.12B Sep/2025
Genmab DKK 629M 127M Jun/2025
Geron USD 87.71M 23.43M Sep/2025
Gilead Sciences USD 12.3B 1.11B Sep/2025
J&J USD 50.87B 3.31B Sep/2025
MacroGenics USD 44.47M 5.47M Sep/2025
Merck USD 28.63B 2.59B Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025
Regeneron Pharmaceuticals USD 4.43B 758.1M Sep/2025
Roche Holding CHF 28B 421M Dec/2025
Xencor USD 86.48M 9.6M Sep/2025